Aquaporin and obesity

December 21, 2005

Dr. Gema Frühbeck, director of the Metabolic Research Laboratory of the University Hospital of the University of Navarra, has published a commentary in the latest issue of Nature. The article presents aquaporin as a new modulator of the biology of the adipocyte. It is a new concept concerning how the permeability of glycerol in fat cells is able to modulate the size of the adipocyte and, as a result, can contribute to the development of obesity.

Aquaporins are related to the transport of water through cell membranes, but only recently has they been linked to weight control and adiposity. There is a subfamily, the aquaglyceroporins, which transport water as well as smaller solutes, such as glycerol. It has been shown that if one eliminates the specific aquaporin of the adipose tissue, aquaporin-7, glycerol is no longer able to leave the fat cell and instead accumulates in the cell interior. That is to say, it produces a hypertrophy of the adipocyte, which if maintained over time, and in many adipocytes simultaneously, results in obesity. It has been shown that this aquaporin-7 also participates in insulin sensitivity. Nevertheless, in humans the loss of this function as a result of gene mutation has not been observed to be associated with the development of obesity or diabetes.

From now on the researchers from this laboratory of the Hospital will have as their objective the deepening of their understanding of the physico-pathologic situation common to human obesity and the evaluation of these channels as a possible means for therapeutic treatment.

Pioneering team
The Multidisciplinary Team of diagnosis and treatment of obesity is a project begun in 1999. Later, the Hospital aided in the creation of the Metabolic Research Laboratory of the University of Navarra.

The principal area of study is research of obesity and related morbidities, from a clinical and molecular point of view. One of the lines of research is directed towards the analysis of intracellular signaling. In particular, we are focusing on the adipocyte and smooth vascular muscle cells, and their linkage with hypertension and cardiovascular diseases.

In collaboration with the area of Cardiovascular Sciences of the CIMA of the University of Navarra, the group which Dr. Frühbeck coordinates studies the participation of leptin in the control of arterial pressure. We are beginning to relate leptin and arterial pressure, especially by means of the liberation of nitric oxide.

The study of the functional relationship between leptin and nitric oxide constitute the axis of other projects in progress at the Metabolic Research Laboratory. Leptin is synthesized primarily by the adipocyte, but there also exist other tissues capable of synthesizing this cytokyne. In addition, the functional receptors of leptin are found in a great quantity of organs, such as, for instance, the liver. Our hypothesis is that leptin can play a beneficial role in liver regeneration, since it is implicated in the intracellular signal cascade typical of the regeneration of damaged tissue.

Implicated factors
It has been theorized for years that obesity has a primordial genetic component: that is, patients tend to be obese because their genes condition them in that direction. The Metabolic Research Laboratory analyses the profile of gene expression in this disease.

There are genes of susceptibility which predispose a person to suffering obesity. Some people are greater savers of energy than others, while other people tend to favor the liberation of energy. Nevertheless, in a single phenotype of obesity there are multiple causes. The current epidemic of obesity is mostly due to sedentary living habits and the changes of living habits, rather than to any particular genetic alteration. Without a doubt, the development and perpetuation of obesity is due to the joint action of external environmental factors in combination with numerous genes.

The Nutrition Society's "Sir David Cuthbertson" medal was awarded to Dr. Gema Frühbeck for her contribution in the investigation of obesity.
-end-
The Nutrition Society is the most prestigious scientific association in Europe dedicated to the study of nutrition. Dr. Frühbeck is the first Spanish researcher to receive the "Sir David Cuthbertson" medal. In fact, it is the first time that that the honour has been awarded to a specialist whose work is based fundamentally outside the United Kingdom.

Elhuyar Fundazioa

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.